NeoGenomics (NEO) director reports RSU release and new stock option grants

Rhea-AI Filing Summary

NEOGENOMICS INC director Marjorie C. Green reported equity compensation activity and an option-related share issuance. She exercised previously reported restricted stock units into 22,964 shares of common stock, which she now holds directly. She also received new awards of 15,970 restricted stock units scheduled to vest on June 1, 2027 and 11,069 stock options exercisable at $10.52 per share expiring on June 1, 2036. A separate option position covering 16,019 underlying shares at an exercise price of $6.95 per share remains outstanding and expires on June 19, 2035. The filing shows only grants and exercises, with no open‑market purchases or sales.

Insider Trade Summary

22,964 shares exercised/converted

Mixed 5 txns

Insider Green Marjorie C

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	22,964	$0.00	--
Grant/Award	Stock Option (Right to Buy)	11,069	$0.00	--
Grant/Award	Restricted Stock Unit	15,970	$0.00	--
Exercise	Common Stock	22,964	$0.00	--
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct, null); Stock Option (Right to Buy) — 11,069 shares (Direct, null); Common Stock — 22,964 shares (Direct, null)

Footnotes (1)

1. Reflects release of restricted stock units that were previously reported on a Form 4. Once vested, the shares of common stock are not subject to expiration.

Key Figures

RSUs exercised to common: 22,964 shares Common shares held: 22,964 shares New RSU grant: 15,970 units +3 more

6 metrics

RSUs exercised to common 22,964 shares Restricted stock units released into common stock on June 1, 2026

Common shares held 22,964 shares Direct holdings after transactions

New RSU grant 15,970 units Restricted stock units vesting June 1, 2027 at $0.00 conversion price

New option grant 11,069 options at $10.52 Stock options expiring June 1, 2036

Existing option position 16,019 underlying shares at $6.95 Stock option expiring June 19, 2035

Derivative exercises 22,964 shares Total derivative shares exercised in this filing

Key Terms

Restricted Stock Unit, Stock Option (Right to Buy), Exercise or conversion of derivative security, Grant, award, or other acquisition

4 terms

Restricted Stock Unit financial

"Security title listed as "Restricted Stock Unit" in the transactions table."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Stock Option (Right to Buy) financial

"Derivative security shown as "Stock Option (Right to Buy)" with exercise prices."

Exercise or conversion of derivative security financial

"Transaction code description states "Exercise or conversion of derivative security" for code M."

Grant, award, or other acquisition financial

"Transaction code description notes "Grant, award, or other acquisition" for new equity awards."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Green Marjorie C

(Last) (First) (Middle)

9490 NEOGENOMICS WAY

(Street)

FORT MYERS FLORIDA 33912

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		M		22,964(1)	A	$0	22,964	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0	06/01/2026		M			22,964	06/01/2026	(2)	Common Stock	22,964	$0	0	D
Stock Option (Right to Buy)	$10.52	06/01/2026		A		11,069		06/01/2027	06/01/2036	Common Stock	11,069	$0	11,069	D
Restricted Stock Unit	$0	06/01/2026		A		15,970		06/01/2027	(2)	Common Stock	15,970	$0	15,970	D
Stock Option (Right to Buy)	$6.95							06/01/2026	06/19/2035	Common Stock	16,019		16,019	D

Explanation of Responses:

1. Reflects release of restricted stock units that were previously reported on a Form 4.

2. Once vested, the shares of common stock are not subject to expiration.

Remarks:

	/s/ Ali Olivo, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did NeoGenomics (NEO) director Marjorie Green report?

Marjorie Green reported equity compensation activity, not market trades. She exercised restricted stock units into 22,964 common shares and received new grants of 15,970 restricted stock units plus 11,069 stock options, all held directly as part of her director compensation.

How many NeoGenomics (NEO) shares does Marjorie Green hold after this Form 4?

Following these transactions, Marjorie Green directly holds 22,964 shares of NeoGenomics common stock. These shares came from the release of previously reported restricted stock units that converted into common stock and are no longer subject to expiration once vested.

What new equity awards did Marjorie Green receive from NeoGenomics (NEO)?

She received 15,970 restricted stock units and 11,069 stock options. The RSUs convert into common stock on June 1, 2027, while the options allow her to buy common shares at $10.52 per share until June 1, 2036, if she chooses to exercise.

Did Marjorie Green buy or sell NeoGenomics (NEO) shares on the open market?

No open-market buys or sells were reported. The Form 4 shows only equity compensation events: an exercise of restricted stock units into 22,964 common shares and grants of new restricted stock units and stock options, all at a reported transaction price of $0.00 per share.

What stock option positions does Marjorie Green have with NeoGenomics (NEO)?

She holds an existing option over 16,019 underlying shares at a $6.95 exercise price expiring June 19, 2035, plus a new option for 11,069 shares at a $10.52 exercise price expiring June 1, 2036, both tied to NeoGenomics common stock.

How many restricted stock units does Marjorie Green still hold in NeoGenomics (NEO)?

After exercising 22,964 previously reported units into common shares, she now holds 15,970 restricted stock units. These remaining units are scheduled to convert into NeoGenomics common stock on June 1, 2027, and carry a stated conversion price of $0.00.